TrialBlood advances2024

Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study.

Kinuko Mitani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.